We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04722887
Brief Title: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency

First Submitted : January 20, 2021
First Submitted that Met QC Criteria : January 20, 2021
First Posted : January 25, 2021

Last Update Submitted that Met QC Criteria : January 13, 2023
Last Update Posted : January 18, 2023